Danaher Co. (NYSE:DHR) is Manitou Investment Management Ltd.’s 10th Largest Position

Manitou Investment Management Ltd. grew its position in shares of Danaher Co. (NYSE:DHR) by 496.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 92,204 shares of the conglomerate’s stock after acquiring an additional 76,755 shares during the period. Danaher comprises 4.9% of Manitou Investment Management Ltd.’s portfolio, making the stock its 10th largest position. Manitou Investment Management Ltd.’s holdings in Danaher were worth $25,635,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. CarsonAllaria Wealth Management Ltd. bought a new position in shares of Danaher during the second quarter valued at approximately $25,000. nVerses Capital LLC purchased a new stake in shares of Danaher during the second quarter valued at approximately $25,000. MFA Wealth Advisors LLC purchased a new stake in shares of Danaher during the second quarter valued at approximately $51,000. Financial Connections Group Inc. purchased a new stake in shares of Danaher during the second quarter valued at approximately $51,000. Finally, Western Pacific Wealth Management LP purchased a new stake in shares of Danaher during the first quarter valued at approximately $55,000. 79.05% of the stock is owned by institutional investors.

Danaher Price Performance

NYSE DHR opened at $245.66 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The firm’s 50 day moving average price is $267.38 and its 200-day moving average price is $260.32. Danaher Co. has a 52-week low of $188.75 and a 52-week high of $281.70. The company has a market cap of $177.44 billion, a PE ratio of 46.88, a P/E/G ratio of 4.45 and a beta of 0.83.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. Danaher’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.02 earnings per share. Sell-side analysts forecast that Danaher Co. will post 7.51 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. Danaher’s payout ratio is currently 20.61%.

Analyst Ratings Changes

A number of equities research analysts have recently commented on DHR shares. The Goldman Sachs Group increased their price target on shares of Danaher from $225.00 to $250.00 and gave the company a “neutral” rating in a report on Wednesday, July 24th. Stifel Nicolaus lifted their target price on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Leerink Partners boosted their price target on shares of Danaher from $275.00 to $280.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Royal Bank of Canada decreased their price target on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Finally, Barclays decreased their price target on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $287.16.

Insider Transactions at Danaher

In related news, SVP Georgeann Couchara sold 952 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the sale, the senior vice president now owns 4,212 shares in the company, valued at approximately $1,130,374.44. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.